Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Baxter
Deloitte
Citi
Queensland Health
Teva
Chubb
Johnson and Johnson
Cerilliant
Daiichi Sankyo

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071111

« Back to Dashboard

NDA 071111 describes AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Barr, Mylan, Sandoz, Teva, and Watson Labs, and is included in five NDAs. It is available from five suppliers. Additional details are available on the AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
Summary for 071111
Tradename:AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Applicant:Barr
Ingredient:amiloride hydrochloride; hydrochlorothiazide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 071111
Suppliers and Packaging for NDA: 071111
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 071111 ANDA Teva Pharmaceuticals USA, Inc. 0555-0483 0555-0483-05 1000 TABLET in 1 BOTTLE (0555-0483-05)
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 071111 ANDA Teva Pharmaceuticals USA, Inc. 0555-0483 0555-0483-02 100 TABLET in 1 BOTTLE (0555-0483-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG ANHYDROUS;50MG
Approval Date:May 10, 1988TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Julphar
Healthtrust
Queensland Health
Dow
Chinese Patent Office
Deloitte
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot